Toxoplasmosis after BMT for CML.

Rapid Detection of Toxoplasma gondii Antigen in Experimentally Infected Mice by Dot- ELISA. Iran J Parasitol (2011) 0.77

Protein expression in E. coli minicells by recombinant plasmids. Cell (1977) 8.74

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood (2001) 5.34

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood (2001) 5.20

The rapid purification of T4 DNA ligase from a lambda T4 lig lysogen. J Biol Chem (1980) 4.82

The effects of self-administering emergency contraception. N Engl J Med (1998) 4.30

Detection of Cervical Carcinoma in the General Population. Br Med J (1963) 3.19

Altered tetracycline resistance in pSC101 recombinant plasmids. Mol Gen Genet (1977) 3.03

On the nature of tetracycline resistance controlled by the plasmid pSC101. Cell (1978) 2.80

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood (2001) 2.61

The aminoglycoside-resistance operon of the plasmid pSa: nucleotide sequence of the streptomycin-spectinomycin resistance gene. Gene (1985) 2.51

The Nithsdale schizophrenia surveys. VIII: Do relatives want family intervention--and does it help? Br J Psychiatry (1991) 2.48

Safe performance of difficult laparoscopic cholecystectomies. Am J Surg (1991) 2.47

Caffeinated beverages and decreased fertility. Lancet (1989) 2.46

Genetic map of the crown gall suppressive IncW plasmid pSa. Mol Gen Genet (1982) 2.33

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. Br J Haematol (1999) 2.24

The use of oral vitamin K for reversal of over-warfarinization. Br J Haematol (2001) 2.12

A rating system for use with patient pain drawings. Pain (1986) 2.10

Early discharge of patients with pulmonary embolism: a two-phase observational study. Eur Respir J (2007) 2.08

Investigation and management of pulmonary infiltrates following bone marrow transplantation: an eight year review. Thorax (1993) 2.08

The Pain Disability Index: psychometric and validity data. Arch Phys Med Rehabil (1987) 2.01

Regulation of Ti plasmid virulence genes by a chromosomal locus of Agrobacterium tumefaciens. J Bacteriol (1985) 1.96

General Dental Council's guidance on anesthesia. J R Soc Med (1999) 1.92

A microsatellite linkage map for Atlantic salmon (Salmo salar). Anim Genet (2004) 1.84

Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med (2001) 1.82

Clinical guidelines for testing for heritable thrombophilia. Br J Haematol (2010) 1.79

Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood (1997) 1.73

Steroid prehormones. Perspect Biol Med (1968) 1.73

Epidemiological aspects of hypertensive pregnancy. Clin Obstet Gynaecol (1977) 1.73

Scottish data on intrapartum related deaths are in same direction as Welsh data. BMJ (1998) 1.72

A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization. Br J Haematol (2000) 1.70

Dielectrophoretic separation and enrichment of CD34+ cell subpopulation from bone marrow and peripheral blood stem cells. Med Biol Eng Comput (1995) 1.68

Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood (1999) 1.68

Prerequisites for successful childbearing. Med Serv J Can (1967) 1.67

The dielectrophoresis enrichment of CD34+ cells from peripheral blood stem cell harvests. Bone Marrow Transplant (1996) 1.65

Consensus Conference on Intensive Chemotherapy Plus Hematopoietic Stem-Cell Transplantation in Malignancies: Lyon, France, June 4-6, 1993. J Clin Oncol (1994) 1.63

Optimal experimental design in an epidermal growth factor receptor signalling and down-regulation model. IET Syst Biol (2007) 1.62

A fifth freedom? Br Med J (1965) 1.60

Identification of pTiC58 plasmid-encoded proteins for virulence in Agrobacterium tumefaciens. Proc Natl Acad Sci U S A (1985) 1.59

Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial. Br J Haematol (2001) 1.58

An improved method of reporting on laryngectomy specimens. J Pathol (1976) 1.55

Use of the polymerase chain reaction to detect Toxoplasma gondii in human blood samples. J Clin Pathol (1992) 1.55

Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 1.50

Flow cytometry in diagnosis and management of large fetomaternal haemorrhage. J Clin Pathol (1995) 1.50

TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. Leukemia (2008) 1.50

Vitamin B12 deficiency following restorative proctocolectomy. Colorectal Dis (2007) 1.49

CD200 as a prognostic factor in acute myeloid leukaemia. Leukemia (2007) 1.49

Age and human reproduction. J Obstet Gynaecol Br Emp (1958) 1.48

Follow-up of 186 sterilised women. Lancet (1968) 1.47

Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol (2001) 1.44

Characteristics of monoclonal immunoglobulins that interfere with serum inorganic phosphate measurement. Ann Clin Biochem (1994) 1.44

The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci (1992) 1.44

DNA repair in Escherichia coli mutants deficient in DNA polymerases I, II and-or 3. Proc Natl Acad Sci U S A (1974) 1.43

Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur J Heart Fail (2002) 1.40

Third party mediated graft rejection despite irradiation of blood products. Br J Haematol (1992) 1.39

Transplantation in first remission of acute myeloid leukemia. N Engl J Med (1998) 1.39

An area maternity service. Lancet (1969) 1.39

Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost (1997) 1.37

Cancer of the uterine cervix in Aberdeenshire. Aetiological aspects. Br J Cancer (1966) 1.37

The influence of induction of labour on caesarean section rate, duration of labour and perinatal mortality in Aberdeen primigravidae between 1938 and 1966. J Obstet Gynaecol Br Commonw (1968) 1.35

Test-retest reliability of the pain drawing instrument. Pain (1988) 1.34

Pain assessment in cognitively impaired and unimpaired older adults: a comparison of four scales. Pain (2001) 1.33

Collagenous colitis: possible response to sulfasalazine and local steroid therapy. Gastroenterology (1985) 1.30

Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia (2007) 1.29

The Pain Disability Index: factor structure and normative data. Arch Phys Med Rehabil (1994) 1.26

Alleles at D6S265 and D6S105 define a haemochromatosis-specific genotype. Br J Haematol (1994) 1.23

A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol (2001) 1.22

Cancer of the uterine cervix in Aberdeenshire. Epidemiological aspects. Br J Cancer (1966) 1.20

Analysis of natural killer effector and suppressor activity by intraepithelial lymphocytes from mouse small intestine. Clin Exp Immunol (1983) 1.18

Internist judgments of chronic low back pain. Pain Med (2000) 1.17

Cardiovascular effects of 50 per cent nitrous oxide and 50 per cent oxygen mixture. Anaesthesia (1973) 1.15

Perinatal mortality. Lancet (1969) 1.14

Cancer and noncancer risk to women in agriculture and pest control: the Agricultural Health Study. J Occup Med (1994) 1.14

Recovery in malignant hypertension presenting as acute renal failure. Q J Med (1984) 1.13

Relationship between social desirability and self-report in chronic pain patients. Clin J Pain (1995) 1.12

Mutant N-RAS induces erythroid lineage dysplasia in human CD34+ cells. J Exp Med (1997) 1.11

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost (2012) 1.11

Isolation of the origin of replication of the IncW-group plasmid pSa. Gene (1982) 1.11

Distribution of leukemia, lymphoma, and allied disease in parts of Great Britain: analysis by administrative districts and simulations of adjacencies. Leukaemia Research Fund 1984 Data Collection Group. Leukemia (1987) 1.11

Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party. Br J Haematol (1997) 1.10

The natural history of membranous nephropathy in the West of Scotland. Q J Med (1986) 1.09

Characterisation of methicillin-resistant Staphylococcus aureus by biotyping, immunoblotting and restriction enzyme fragmentation patterns. J Med Microbiol (1990) 1.08

Molecular characterization of the virC genes of the Ti plasmid. J Bacteriol (1987) 1.08

'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang (2004) 1.08

Molecular mimicry of an HLA-DR53 epitope by viruses. Immunol Today (1994) 1.08

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Leukemia (2011) 1.07

Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses: comment. J Thromb Haemost (2014) 1.07

The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia. Leukemia (2013) 1.07

Environment and reproduction. Br J Obstet Gynaecol (1980) 1.06

Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost (2010) 1.06

Neisseria catarrhalis septicaemia in acute lymphoblastic leukaemia. Scott Med J (1975) 1.06

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer (1999) 1.06

Influence of Agricultural Practices on the Levels of DDT and Its Residues in Soil. Environ Sci Technol (1994) 1.05

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer (2004) 1.04

Protective effect of pregnancy for development of uterine leiomyoma. Carcinogenesis (2001) 1.03

The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol (Oxf) (1991) 1.02

The epidemiology of low birth weight; changes in incidence in Aberdeen, 1948-72. J Biosoc Sci (1974) 0.99

Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol (1983) 0.98

Sterilization and therapeutic abortion in Aberdeen. Br J Psychiatry (1967) 0.98

Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal. Leukemia (2004) 0.98

Restriction endonuclease mapping of pSC101 and pMB9. Mol Gen Genet (1978) 0.97